Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence | Arteriosclerosis, Thrombosis, and Vascular Biology
Plasminogen activator inhibitor-1 - Wikipedia
Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome | Arteriosclerosis, Thrombosis, and Vascular Biology
Figure 2 from Plasminogen activator inhibitor-1 gene polymorphisms in pre-eclampsia. | Semantic Scholar
structural characteristics of the PAI-1 and PAR-1 genes and the results... | Download Scientific Diagram
Global Gene Expression Profiling in PAI-1 Knockout Murine Heart and Kidney: Molecular Basis of Cardiac-Selective Fibrosis | PLOS ONE
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease | NEJM
Plasminogen activator inhibitor-1 - Wikipedia
Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis | Cell Communication and Signaling | Full Text
Role of PAI-1 in hepatic steatosis and dyslipidemia | Scientific Reports
Plasminogen Activator Inhibitor Type‐1 as a Regulator of Fibrosis - Rabieian - 2018 - Journal of Cellular Biochemistry - Wiley Online Library
Structure of PAI-1 gene showing site of 4G/5G polymorphism 675bp... | Download Scientific Diagram
Bezafibrate Induces Plasminogen Activator Inhibitor-1 Gene Expression in a CLOCK-Dependent Circadian Manner | Molecular Pharmacology
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity | Journal of Neuroinflammation | Full Text